Question 1

What are the most cited papers from KoreaBio?

Accepted Answer

The most cited paper from KoreaBio is "Development of a Universal Fluorescent Probe for Gram‐Positive Bacteria" (Haw‐Young Kwon, Xiao Liu, Eun Gyeong Choi et al., 2019), with 120 citations. Next come "Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults" (61) and "The Classification and Prognosis of Periocular Complications Related to Blindness following Cosmetic Filler Injection" (57).

Question 2

Which research topics does KoreaBio publish most on?

Accepted Answer

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, RNA modifications and cancer and HER2/EGFR in Cancer Research.

Question 3

Which fields of science does KoreaBio work in?

Accepted Answer

In all years, 51% of research at KoreaBio is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (33%), Agricultural and Biological Sciences (8%). It does 2.2× the world's share of Life Sciences.

Question 4

Is KoreaBio's research output growing?

Accepted Answer

Output in 2022-2025 was 273% higher than in 2018-2021.